Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.7200 (-0.11%) ($17.6700 - $18.0700) on Wed. Oct. 18, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 55 | Latest Price | $17.7200(-0.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.7% a day on average for past five trading days. | Weekly Trend | HALO advances 0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(56%) IWO(55%) XBI(53%) IWM(50%) ARKG(49%) | Factors Impacting HALO price | HALO will decline at least -1.555% in a week (0% probabilities). VIXM(-13%) UUP(-11%) TLT(-6%) SHY(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $17.71(0.06%) | 10 Day Moving Average | $17.4(1.84%) | 20 Day Moving Average | $17.28(2.55%) | To recent high | -0.8% | To recent low | 50.7% | Market Cap | $2.422b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |